The one-two punch: knocking out angiotensin II in the heart.

about

Cardiac remodelling and RAS inhibition CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation.

P2860

Q28076749-C809FA69-48EF-42E7-897C-B30BE243526C Q36337179-24A35848-983D-4A14-BFC1-58A7748A8DC0 Q39168612-711BB9EA-9943-4293-8D29-42BC0A6D3601

P2860

The one-two punch: knocking out angiotensin II in the heart.

Item

http://www.wikidata.org/entity/Q39813086

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

The one-two punch: knocking out angiotensin II in the heart.

@en

The one-two punch: knocking out angiotensin II in the heart.

@nl

type

Item

label

The one-two punch: knocking out angiotensin II in the heart.

@en

The one-two punch: knocking out angiotensin II in the heart.

@nl

prefLabel

The one-two punch: knocking out angiotensin II in the heart.

@en

The one-two punch: knocking out angiotensin II in the heart.

@nl

P1476

The one-two punch: knocking out angiotensin II in the heart

@en

P2093

Daniela Zablocki

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

The renin-angiotensin system in the twenty-first century.

Pathways for bradykinin formation and inflammatory disease.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

The intracellular renin-angiotensin system: implications in cardiovascular remodeling.

P304

1028-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI42644

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Junichi Sadoshima

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42541844

http://www.w3.org/2001/XMLSchema#string

P698

20335650

http://www.w3.org/2001/XMLSchema#string

P932

2846074

http://www.w3.org/2001/XMLSchema#string

The one-two punch: knocking out angiotensin II in the heart.

about

P2860

P2860

The one-two punch: knocking out angiotensin II in the heart.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932